정기훈 (서울대학교 의과대학)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학

CV File

면역학

최종업데이트 2025.03.17.

Single-cell transcriptomics of the myeloid milieu reveals an angiogenic niche in triple-negative breast cancer
- Exp. Mol. Med., Nov 07 2025, | https://doi.org/10.1038/s12276-025-01571-5
- 2025-11
- 생명과학
- 한빛사논문
Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers
- Mol. Cancer, Mar 14 2025, 24 (1) | https://doi.org/10.1186/s12943-025-02256-3
- 2025-03
- 한빛사논문
[Journal Club] The recruitment of metastasis-associated monocytes
- Nat. Rev. Cancer, Sep 18 2024, | https://doi.org/10.1038/s41568-024-00753-z
- 2024-09
- 생명과학
- 한빛사논문
Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
- Exp. Mol. Med., 01 November 2023 | https://doi.org/10.1038/s12276-023-01114-w
- 2023-11
- 생명과학
- 한빛사논문
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes
- Nat. Cancer, Published: 22 December 2022 | doi: 10.1038/s43018-022-00479-7
- 2022-12
- 바이오·의료융합
- 한빛사논문
PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer
- Nat. Commun., Published 22 October 2022 | https://doi.org/10.1038/s41467-022-33991-6
- 2022-10
- 생명과학
- 한빛사논문
MarcoPolo: a method to discover differentially expressed genes in single-cell RNA-seq data without depending on prior clustering
- Nucleic Acids Res., Published: 14 April 2022 | https://doi.org/10.1093/nar/gkac216
- 2022-04
- 의약학
- 한빛사논문
Nano-assembly of a Chemically Tailored Cas9 Ribonucleoprotein for In Vivo Gene Editing and Cancer Immunotherapy
- Chem. Mater., Publication Date:December 20, 2021 | https://doi.org/10.1021/acs.chemmater.1c02844
- 2021-12
- 바이오·의료융합
- 한빛사논문
- 정기훈(Harvard Medical School)
Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer
- Proc. Natl. Acad. Sci. USA, Published online before print September 12, 2017 | doi: 10.1073/pnas.1710754114
- 2017-09
- 생명과학
- 한빛사논문
- 정기훈(Harvard Medical School and Massachusetts General Hospital)
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
- J. Clin. Invest., Published July 10, 2017 | doi:10.1172/JCI93182
- 2017-07
- 생명과학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기